ImportRefusal LogoImportRefusal

Huons Co., Ltd.

⚠️ Moderate Risk

FEI: 3007163376 • Jecheon, Chungcheongbuk • SOUTH KOREA

FEI

FEI Number

3007163376

📍

Location

Jecheon, Chungcheongbuk

🇰🇷
🏢

Address

100 Bio-Valley-Ro, , Jecheon, Chungcheongbuk, South Korea

Moderate Risk

FDA Import Risk Assessment

43.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

6
Total Refusals
6
Unique Violations
3/21/2024
Latest Refusal
3/10/2005
Earliest Refusal

Score Breakdown

Violation Severity
59.2×40%
Refusal Volume
31.3×30%
Recency
49.4×20%
Frequency
3.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4723×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

821×

RX LEGEND

The article appears to be a prescription drug without a prescription drug legend as required by Section 503(b)(4).

Refusal History

DateProductViolationsDivision
3/21/2024
60CCK04EPINEPHRINE (ADRENERGIC)
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/21/2024
65RCK19SODIUM CHLORIDE (REPLENISHER)
472NO ENGLISH
Division of Southeast Imports (DSEI)
6/21/2019
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
237NO PMA
Division of West Coast Imports (DWCI)
7/10/2018
66VIP99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
472NO ENGLISH
82RX LEGEND
Division of Southeast Imports (DSEI)
10/12/2011
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
3/10/2005
55RP74DEXTROSE (PHARMACEUTIC NECESSITY)
118NOT LISTED
75UNAPPROVED
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Huons Co., Ltd.'s FDA import refusal history?

Huons Co., Ltd. (FEI: 3007163376) has 6 FDA import refusal record(s) in our database, spanning from 3/10/2005 to 3/21/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Huons Co., Ltd.'s FEI number is 3007163376.

What types of violations has Huons Co., Ltd. received?

Huons Co., Ltd. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Huons Co., Ltd. come from?

All FDA import refusal data for Huons Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.